Cardiovascular Disease
CV event risk could increase shortly after spouse’s ICU admission
Patients with a spouse who was admitted to the ICU may have increased risk for CV events in the few weeks after ICU admission, researchers found.
‘Evidence of synergy’: Short sleep, hot flashes associated with CV risk in menopause
Frequent hot flashes are associated with indicators of cardiovascular disease among midlife and older women; poor sleep and trauma history may act synergistically with vasomotor symptoms to further increase risk, according to a speaker.
Income disparities in CVD incidence increased from 1999 to 2016
Disparities in CVD prevalence substantially increased from 1999 to 2016 between patients with high resources and low resources, with the highest-resources group having a lower CVD rate compared with other groups, researchers found.
Early-onset type 2 diabetes risk elevated for South Asian, African Caribbean adults
South Asian and African Caribbean adults living in north west London are more likely to be diagnosed with early-onset type 2 diabetes than white adults, according to a speaker.
Q&A: In-vehicle ECG monitoring could prevent traffic accidents caused by CV events
In-vehicle cardiac monitoring for older drivers may reduce their risk for heart-related traffic accidents, according to a researcher.
CVD, stroke risks increase with number of menopause symptoms
Women who reported two or more moderate to severe menopause symptoms had increased risks for cardiovascular disease and stroke, but vasomotor symptom severity did not affect risk, according to data from the WHI Calcium and Vitamin D trial.
Diabetes in pregnancy leads to elevated risk for CVD in offspring
Exposure to diabetes in utero was associated with an elevated risk for CVD events and risk factors in offspring from the ages of 10 to 35 years, according to research published in CMAJ.
Combined hydroxychloroquine, azithromycin use increases cardiovascular risk in RA
The combination of hydroxychloroquine and azithromycin significantly increased risk for heart failure and cardiovascular mortality among patients with rheumatoid arthritis, according to data published in The Lancet Rheumatology.
DAPA-CKD: Dapagliflozin prolongs survival in CKD with, without type 2 diabetes
Treatment with dapagliflozin significantly reduced renal failure, cardiovascular death or hospitalization for heart failure, and prolonged survival among adults with chronic kidney disease with and without type 2 diabetes, study data show.
Clock indicating critical points throughout stroke care may expedite treatment
Acute stroke management metrics improved with use of an alarm clock in the CT room that indicated several target times up to therapy decision, researchers found.